These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7510573)

  • 1. The Urolume as a means of treating urinary outflow obstruction and its impact on waiting lists.
    Schneider HJ; De Souza JV; Palmer JH
    Br J Urol; 1994 Feb; 73(2):181-4. PubMed ID: 7510573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
    Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
    BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UroLume as a means of treating urinary outflow obstruction and its impact on waiting lists.
    Williams G
    Br J Urol; 1994 Sep; 74(3):393. PubMed ID: 7953283
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.
    Anjum MI; Chari R; Shetty A; Keen M; Palmer JH
    Br J Urol; 1997 Dec; 80(6):885-8. PubMed ID: 9439402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UroLume stent in the management of benign prostatic hyperplasia.
    Milroy E; Chapple CR
    J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anatomy of a prostate waiting list: a prospective study of 132 consecutive patients.
    Schou J; Poulsen AL; Nordling J
    Br J Urol; 1994 Jul; 74(1):57-60. PubMed ID: 7519113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
    Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
    Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency heat-treatment to the prostate for bladder outlet obstruction associated with benign prostatic hyperplasia: a 4-year outcome study.
    Dawkins GP; Harrison NW; Ansell W
    Br J Urol; 1997 Jun; 79(6):910-4. PubMed ID: 9202558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urethral stent (Angiomed-Memotherm) implantation in high-risk patients with urinary retention.
    Uchikoba T; Horiuchi K; Satoh M; Oka F; Saitoh Y; Tsuboi N; Nishimura T
    Hinyokika Kiyo; 2005 Apr; 51(4):235-9. PubMed ID: 15912781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A urodynamic study of laser ablation of the prostate and a comparison of techniques.
    James MJ; Harriss DR; Ceccherini A; Manhire AR; Bates CP
    Br J Urol; 1995 Aug; 76(2):179-83. PubMed ID: 7545062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres.
    Williams G; Coulange C; Milroy EJ; Sarramon JP; Rubben H
    Br J Urol; 1993 Sep; 72(3):335-40. PubMed ID: 7693296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostakath in urinary outflow obstruction.
    Ala-Opas M; Talja M; Tiitinen J; Hellström P; Heikkinen A; Nurmi M
    Ann Chir Gynaecol Suppl; 1993; 206():14-8. PubMed ID: 7507307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prostakath stent: four years' experience.
    Thomas PJ; Britton JP; Harrison NW
    Br J Urol; 1993 Apr; 71(4):430-2. PubMed ID: 7684649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolume stent placement for the treatment of postbrachytherapy bladder outlet obstruction.
    Konety BR; Phelan MW; O'Donnell WF; Antiles L; Chancellor MB
    Urology; 2000 May; 55(5):721-4. PubMed ID: 10792088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the second generation UroLume prostatic stent.
    Bajoria S; Agarwal SA; White R; Zafar F; Williams G
    Br J Urol; 1995 Mar; 75(3):325-7. PubMed ID: 7735798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
    Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
    Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic stents for the treatment of benign prostatic hyperplasia.
    Vanderbrink BA; Rastinehad AR; Badlani GH
    Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
    Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
    J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
    Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
    Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.